Lactose India Ltd. engages in manufacturing of pharmaceutical and other pharmaceutical products. The company is headquartered in Mumbai, Maharashtra. The firm principally engaged in the manufacturing of lactose monohydrate. The Company’s products are available in various segments, such as liquid dosage form, solid dosage forms, excipients and active pharmaceutical ingredients. The company manufactures disaccharide lactulose. The company manufactures dry granulated, film and lacquer coated tablets. The firm is also engaged in producing pharma color coatings in a room facility, which has an installed capacity of approximately 180 metric tons/annum. The firm offers prebiotic-galacto-oligosaccharides (GOS), which is used in various applications, such as dairy products, beverages, bakery products, infant nutrition, clinical nutrition, products for children or adolescents, and geriatric nutrition. The firm's plant is located at Taluka Savli, Vadodara, Gujarat.
Loading chart…
Our models read the latest earnings call, annual report, and financials end-to-end - then grade management, value the business, and flag the risks. Unlock all of it for this company:
The headline call - descriptive label, conviction, and the synthesis behind it.
Guidance-anchored P&L bridge - worst / average / best multiple cases.
Did management deliver on past guidance? A commitment-by-commitment scorecard.
Forensic and governance risk pointers, severity-ranked.
Solvency and earnings-quality score.
Quarter-by-quarter earnings-call briefs - what changed and why.